Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 362.68B | 359.46B | 336.91B | 282.09B | 273.61B | 291.30B |
Gross Profit | 115.85B | 103.82B | 95.20B | 75.79B | 74.56B | 79.09B |
EBITDA | 39.88B | 37.97B | 33.61B | 24.50B | 28.05B | 25.93B |
Net Income | 16.17B | 13.02B | 16.23B | 5.87B | 2.15B | 954.00M |
Balance Sheet | ||||||
Total Assets | 274.75B | 316.82B | 299.36B | 280.81B | 264.33B | 249.66B |
Cash, Cash Equivalents and Short-Term Investments | 43.50B | 57.87B | 59.74B | 53.47B | 61.42B | 40.79B |
Total Debt | 108.31B | 57.30B | 62.48B | 69.84B | 75.59B | 74.60B |
Total Liabilities | 227.93B | 195.60B | 195.63B | 196.85B | 195.80B | 189.66B |
Stockholders Equity | 45.90B | 114.80B | 98.81B | 79.50B | 64.64B | 56.48B |
Cash Flow | ||||||
Free Cash Flow | 21.30B | 12.16B | 10.79B | -8.90B | 21.92B | 527.00M |
Operating Cash Flow | 39.19B | 33.17B | 26.61B | 7.06B | 35.83B | 21.64B |
Investing Cash Flow | -19.89B | -16.06B | -7.33B | -9.80B | -11.80B | -19.68B |
Financing Cash Flow | -19.13B | -19.35B | -14.03B | -11.27B | -5.34B | -1.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥3.61T | 9.85 | 7.85% | 2.57% | -0.45% | -17.53% | |
73 Outperform | ¥248.13B | 30.92 | 3.45% | 4.09% | -2.63% | -31.17% | |
71 Outperform | $23.16T | 20.08 | 14.32% | 0.54% | -0.49% | 19.71% | |
71 Outperform | ¥174.13B | 8.54 | 16.78% | 1.73% | 3.02% | 60.53% | |
68 Neutral | ¥81.41B | 20.30 | 2.65% | 0.52% | -44.10% | ||
67 Neutral | ¥251.03B | 12.88 | 6.57% | 2.80% | 5.06% | -11.39% | |
61 Neutral | $2.43T | 100.87 | 0.71% | 2.90% | 0.51% | -76.08% |